Four most prevalent clusters, by sex group (N (women)=217 823; N (men)=191 171)
| Prevalence | Prevalence | Blocks of diagnoses | Prevalence in group‡, | Prevalence in cluster, | AU P value§ |
| 1, %* | 2, %† | % | % | ||
| Women | |||||
| WC1¶ | 52.9 | M50–M54: other dorsopathies | 35.8 | 43.5 | 0.79 (0.74–0.85) |
| 82.1 | F40–F48: neurotic, stress-related and somatoform disorders | 27.3 | 33.2 | ||
| M70–M79: other soft-tissue disorders | 27.0 | 32.8 | |||
| N80–N98: non-inflammatory disorders of female genital tract | 24.2 | 29.5 | |||
| M20–M25: other joint disorders | 18.6 | 22.6 | |||
| I80–I89: diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | 18.3 | 22.2 | |||
| D10–D36: benign neoplasms | 16.2 | 19.7 | |||
| M15–M19: arthrosis | 15.7 | 19.1 | |||
| WC2 | 23.0 | E70–E90: metabolic disorders | 37.4 | 63.4 | 0.93 (0.86–1.00) |
| 55.8 | I10–I15: hypertensive diseases | 25.6 | 45.8 | ||
| E65–E68: obesity and other hyperalimentation | 19.0 | 34.0 | |||
| E10–E14: diabetes mellitus | 7.7 | 13.7 | |||
| WC3 47.4 | 10.8 | F10–F19: mental and behavioural disorders due to psychoactive substance use | 18.7 | 39.4 | 0.78 (0.73–0.84) |
| E00–E07: disorders of thyroid gland | 14.9 | 31.4 | |||
| F30–F39: mood (affective) disorders | 14.6 | 30.8 | |||
| M80–M85: disorders of bone density and structure | 11.3 | 23.9 | |||
| WC4 | 6.4 | J00–J06: acute upper respiratory infections | 12.6 | 39.1 | 0.71 (0.66–0.77) |
| 32.3 | K00–K14: diseases of oral cavity, salivary glands and jaws | 12.1 | 37.3 | ||
| L20–L30: dermatitis and eczema | 9.3 | 28.8 | |||
| B35–B49: mycoses | 5.7 | 17.8 | |||
| Men | |||||
| MC1** | 50.4 | E70–E90: metabolic disorders | 42.2 | 50.3 | 0.69 (0.64–0.75) |
| 83.8 | F10–F19: mental and behavioural disorders due to psychoactive substance use | 33.6 | 40.1 | ||
| I10–I15: hypertensive diseases | 32.5 | 38.8 | |||
| M50–M54: other dorsopathies | 27.8 | 33.2 | |||
| E65–E68: obesity and other hyperalimentation | 14.6 | 17.4 | |||
| E10–E14: diabetes mellitus | 14.2 | 16.9 | |||
| MC2 | 24.2 | M70–M79: other soft tissue disorders | 16.9 | 29.3 | 0.87 (0.84–0.90) |
| 57.6 | N40–N51: diseases of male genital organs | 12.1 | 21.0 | ||
| M20–M25: other joint disorders | 12.1 | 20.9 | |||
| K20–K31: diseases of oesophagus, stomach and duodenum | 11.5 | 20.0 | |||
| I80–I89: diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | 10.0 | 17.4 | |||
| K40–K46: hernia | 8.8 | 15.2 | |||
| D10–D36: benign neoplasms | 8.6 | 14.9 | |||
| M15–M19: arthrosis | 7.7 | 13.4 | |||
| K55–K63: other diseases of intestines | 6.4 | 11.1 | |||
| MC3 | 20.7 | F40–F48: neurotic, stress-related and somatoform disorders | 13.5 | 24.9 | 0.79 (0.74–0.84) |
| 54.1 | K00–K14: diseases of oral cavity, salivary glands and jaws | 12.0 | 22.3 | ||
| J40–J47: chronic lower respiratory diseases | 9.3 | 17.2 | |||
| J00–J06: acute upper respiratory infections | 8.9 | 16.4 | |||
| J30–J39: other diseases of upper respiratory tract | 8.0 | 14.8 | |||
| L20–L30: dermatitis and eczema | 7.5 | 13.9 | |||
| G40–G47: episodic and paroxysmal disorders | 7.4 | 13.7 | |||
| F50–F59: behavioural syndromes associated with physiological disturbances and physical factors | 6.6 | 12.2 | |||
| F30–F39: mood (affective) disorders | 6.3 | 11.6 | |||
| B35–B49: mycoses | 4.1 | 7.6 | |||
| MC4 | 4.7 | H90–H95: other disorders of ear | 7.7 | 30.6 | 0.87 (0.83–0.91) |
| 25.2 | H53–H54: visual disturbances and blindness | 3.9 | 15.5 | ||
| B00–B09: viral infections characterised by skin and mucous membrane lesions | 3.5 | 13.9 | |||
| L60–L75: disorders of skin appendages | 3.5 | 13.9 | |||
| H10–H13: disorders of conjunctiva | 3.0 | 12.0 | |||
| H49–H52: disorders of ocular muscles, binocular movement, accommodation and refraction | 2.8 | 11.2 | |||
| L80–L99: other disorders of the skin and subcutaneous tissue | 2.5 | 10.0 | |||
| L00–L08: infections of the skin and subcutaneous tissue | 2.1 | 8.3 | |||
| H00–H06: disorders of eyelid, lacrimal system and orbit | 1.6 | 6.5 | |||
*Individuals from the strata ≥1 diagnosis in the cluster.
†Individuals from the strata with ≥2 diagnosis in the cluster.
‡Strata: same sex.
§Approximately unbiased (AU) probability value.
¶Abbreviation of sex, method and number (WC1: women cluster 1).
**Abbreviation of sex, method and number (MC1: men cluster 1).